of improving the poor specificity of 'P-amylase' measurement in macroamylasaemia, state that 'pancreatic amylase assay appears to be a specific test for pancreatic disease'. This is both incorrect and not supported by the cited literature.
In particular Massey,' whom they quote, clearly refers to the P J isoenzyme, separated by electrophoresis, and not to total pancreatic amylase. Unlike total pancreatic amylase, P J has been shown to be highly specific for acute pancreatitis. 'P-amylase' is not strictly defined in this paper but seems to refer to total pancreatic amylase (as indicated by the pancreatic fluid data). Total pancreatic amylase is predominantly P, isoenzyme, both in normal subjects and during the acute disease process.
The specificity of total pancreatic amylase may well be high when comparing acute pancreatitis with causes of salivary amylase elevation (such as mumps). The test will be much less specific in clinically realistic situations such as acute abdomen. Common conditions such as biliary obstruction will often elevate pancreatic amylase probably due to local inflammatory effects.
The P J isoenzyme is thought to be derived from post transcriptional modification of P, in response to necrosis or other trauma within the pancreas. Unlike P, it is virtually absent in normal tissue or sera. It is more specific for acute pancreatitis.P:' P J also reflects the course of the disease process unlike total amylase or total pancreatic amylase."
In chronic renal failure, another cause of moderate hyperamylasaemia, both pancreatic and salivary amylase can be elevated. In my own series of 16 patients with this condition 10 had hyperamylasaemia. The percentage of P, varied from 30% to 70%, a similar distribution to normals. In no case, however, was there a false positive increase in P J . J Specificity depends critically on the population chosen. Nevertheless, in the reference cited' the specificity of P, was only 91% compared to 98% for P J • Worse still, the positive predictive value of P 2 was 45%, only a little better than total amylase (30%), compared to 82% for P J • To dismiss lipase measurement because of lack of specificity is dubious. Steinberg et al? showed
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Ann Clin Biochem 1990; 27: 169-l71 a specificity of 99% for lipase compared to 85% for pancreatic amylase and with improved techniques lipase has recently been suggested as a second line test after total amylase, followed only in diagnostic dilemmas such as macroamylasaemia by electrophoresis."
As suggested, electrophoresis is probably not an emergency test. It is slow (although that it is necessarily expensive is disputable). Ideally a simple monoclonal antibody assay for the P J isoenzyme should be developed. In the mean time commercial tests of 'P amylase' may be better than total amylase, but our surgical colleagues (and their patients) will not thank us if we make misinformed claims as to its specificity. Mr Frost's letter provides us with the opportunity to clarify a few points raised in our paper. I 'P-amylase' is total pancreatic amylase activity. Lipase measurement (as well as other parameters) has been reviewed extensively, and different conclusions have been reached. We did not Our preferred investigation of hyperamylasaemia is illustrated by means of a flow-chart. It shows that, after total amylase was found to be high, P-amylase determination (eventually together with PEG-precipitation) follows as a secondary screen. If this value is still elevated one could proceed to electrophoresis in order to demonstrate p]. This may not be applicable to a very large hospital with many acute abdomens to be investigated.
'Pancreatic disease' was a general term, meant to include all conditions affecting the pancreas and its secretion, be it primarily or secondarily as in the case of biliary obstruction given by Frost. Massey] advocates electrophoresis and P, detection. Although it is clear from Mr Frost that total pancreatic amylase must be a specific parameter, Massey also describes differentiation of hyperamylasaemia caused by aspiration of saliva by determination of total P-amylase. This is exactly what we wanted to do, but with an automated test. Since we have demonstrated the good correlation between electrophoresis and Pamylase measurement, we cited Massey as a reference to say that P-amylase is specific for pancreatic involvement in disease.
